28
Participants
Start Date
April 30, 2008
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
Rapamycin (liquid)
Weekly Rapamycin (liquid) 90mg (dose will be split 45mg on Day 1 and Day 2 of each week)
Bevacizumab
Multiple doses (dose depends on time of study entry) given by IV once every 3 weeks
Rapamycin (Tablets)
Daily oral rapamycin (tablets) - 2 doses will be tested 4mg and 6mg
University of Chicago, Chicago
Collaborators (1)
Genentech, Inc.
INDUSTRY
University of Chicago
OTHER